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Abstract
Endoplasmic reticulum (ER) stress-induced apoptosis has been implicated in various neurodegenerative diseases including
Parkinson Disease, Alzheimer Disease and Huntington Disease. PUMA (p53 upregulated modulator of apoptosis) and BIM
(BCL2 interacting mediator of cell death), pro-apoptotic BH3 domain-only, BCL2 family members, have previously been
shown to regulate ER stress-induced cell death, but the upstream signaling pathways that regulate this response in
neuronal cells are incompletely defined. Consistent with previous studies, we show that both PUMA and BIM are induced in
response to ER stress in neuronal cells and that transcriptional induction of PUMA regulates ER stress-induced cell death,
independent of p53. CHOP (C/EBP homologous protein also known as GADD153; gene name Ddit3), a critical initiator of ER
stress-induced apoptosis, was found to regulate both PUMA and BIM expression in response to ER stress. We further show
that CHOP knockdown prevents perturbations in the AKT (protein kinase B)/FOXO3a (forkhead box, class O, 3a) pathway in
response to ER stress. CHOP co-immunoprecipitated with FOXO3a in tunicamycin treated cells, suggesting that CHOP may
also regulate other pro-apoptotic signaling cascades culminating in PUMA and BIM activation and cell death. In summary,
CHOP regulates the expression of multiple pro-apoptotic BH3-only molecules through multiple mechanisms, making CHOP
an important therapeutic target relevant to a number of neurodegenerative conditions.
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Introduction
The ability to sense perturbations in the function of the ER is
critical to eukaryotic cell survival. ER stress triggers an evolution-
arily conserved intracellular response called the Unfolded Protein
Response (UPR) in an attempt to restore cellular homeostasis [1].
The evolutionarily oldest branch of the UPR is triggered by the
activation of a combined nuclease and kinase called IRE1 (inositol
requiring protein-1). A second branch of the UPR is initiated by
activation of the kinase PERK (protein kinase RNA (PKR)-like ER
kinase), which similarly to IRE1, responds to ER stress by
autophosphorylation and homomultimerization. A third branch of
the UPR involves the protease-mediated activation of a transcrip-
tional factor called ATF6 (activating transcription factor-6) [2].
The UPR strives to maintain ER function during stress; however,
if the stress is not resolved, apoptotis is activated [3,4]. Death
inducing signals from the ER are integrated and amplified at the
mitochondria and mouse embryonic fibroblasts from Bax
2/2Bak
2/2 mice are resistant to ER stress induced-apoptosis, indicating a
critical role for BAX and BAK in ER stress-triggered death [3].
Emerging evidence has implicated ER stress-induced apoptosis in
a variety of chronic diseases such as diabetes, ischemia and
neurodegenerative diseases [5–7].
Whether stressed cells live or die is largely determined by the
interplay between pro-apoptotic and anti-apoptotic members of
the BCL2 protein family [8]. The BH3-only proteins monitor
cellular well-being and, when activated by cytotoxic signals,
interact with pro-survival BCL2 relatives leading to downstream
BAX and BAK activation and cell death by permeabilization of
the outer mitochondrial membrane [9]. Different cell types may
require different BH3-only proteins to activate apoptosis in
response to the same cellular stress, while within a given cell type
different BH3-only proteins may be required for activating the
apoptosis machinery in response to different stimuli [10,11]. Based
on recent progress in the study of BH3-only proteins, it has
become clear that they have individual differences not only in the
pathways through which they are activated or induced but also in
their function. The emerging diversity in the function of BH3-only
proteins indicates that they are involved in more intricate
molecular interplay than previously estimated, allowing them to
regulate apoptosis in a more efficient manner. PUMA and BIM
are the most potent of the pro-apoptotic BH3-only proteins due to
their ability to bind to and neutralize all pro-survival BCL2
members [12]. Both PUMA and BIM have been implicated as key
initiators of the apoptotic machinery in response to prolonged ER
stress [13,14]. BIM is essential for ER stress-induced apoptosis in a
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epithelial cells from breast or kidney, though different BH3-only
proteins have also been implicated in this process. Gene expression
profiling showed that PUMA and not BIM is transcriptionally
induced in neuroblastoma cells undergoing ER stress, and RNAi-
mediated suppression of PUMA protected HCT116 cells against
thapsigargin-induced apoptosis, albeit not completely [13]. Alter-
nately, PUMA as well as NOXA were reported to be critical
mediators of ER stress-induced apoptosis in MEF’s in a p53-
dependent manner [15]. It is thus conceivable that BIM
cooperates with PUMA in this apoptotic pathway and may
regulate cell death to varying extents in different cell types in
response to ER stress. ER stress was shown to activate BIM
through two novel pathways, involving protein phosphatase 2A-
mediated dephosphorylation, which prevents its ubiquitination
and proteasomal degradation and CHOP-mediated direct tran-
scriptional induction [14]. In another recent study, CHOP was
shown to bind to the Puma promoter during ER stress and CHOP
knockdown attenuated PUMA induction and neuronal apoptosis
[16].
CHOP is thought to be the critical mediator of ER stress-
induced apoptosis and studies using Chop-null mice have estab-
lished the role of CHOP in ER stress-induced apoptosis in a
number of disease models [17–21]. CHOP is present in the cytosol
under non-stressed conditions and ER stress leads to its induction
and nuclear accumulation [22]. Expression of CHOP is mainly
regulated at the transcriptional level [23], though CHOP protein
undergoes phosphorylation by the p38 MAP kinase family which
enhances its transcriptional ability and the apoptotic response
[24,25]. FOXO3a (forkhead box, class O, 3a) belongs to the family
of mammalian forkhead transcription factors, including FOXO3a
(or FKHRL1), FOXO1a (or FKHR), and FOXO4a (or AFX),
which are regulated by growth factor receptor-induced activation
of the phosphatidylinositol 3-kinase (PI3K)/AKT (or protein
kinase B) signaling pathway [26–28]. Activation of AKT causes
phosphorylation of forkhead transcription factors, in the case of
FOXO3a at the threonine32, serine253, and serine315 sites [26].
Phosphorylation of FOXO3a promotes its redistribution from the
nucleus to the cytosol and therefore reduces its DNA binding and
transcriptional activity [29]. Studies in mammalian cells have
shown that activation of FOXO3a by decreasing its phosphory-
lation and increasing its nuclear content can stimulate the
expression of proteins that are involved in either apoptosis [26]
or cell cycle arrest [30] in different types of cells. FOXO3a is an
important regulator of BIM expression in neurons in response to
NGF withdrawal [31] and alterations in the AKT-FOXO3a axis
have been reported to affect BIM expression in neurons in
response to hypoxia-ischemia [32] or ER stress [33]. FOXO3a has
also emerged as a key transcriptional regulator of PUMA
expression in response to cytokine withdrawal [34] and other
cytotoxic stimuli [35,36].
In the present study, we examined the role of CHOP in
mediating the induction of PUMA and BIM in response to ER
stress in neuronal cells and assessed the potential interaction of
CHOP with FOXO3a in an attempt to gain further mechanistic
insights linking CHOP to the activation of pro-apoptotic BH3-
only family members.
Materials and Methods
Mice
The generation of mice deficient for Puma and Bim have been
previously described [37,38]. p53
2/2 mice were purchased from
Taconic (Germantown, NY). All mice were backcrossed for at least
6 generations onto the C57BL/6J background. The morning on
which a vaginal plug was seen was designated as embryonic Day
0.5 (E0.5). Pregnant mice were anesthetized with methoxyflurane
and sacrificed on gestational day 14 by cervical dislocation.
Embryos (E14.5) were removed for generation of telencephalic
neuronal cultures and tail and limb samples were taken for DNA
extraction and PCR analyses. Mice were housed and cared for
according to the NIH Guide for the Care and Use of Laboratory Animals
and the Institutional Animal Care Committee of the University of
Alabama at Birmingham. All animal protocols were approved by
the Institutional Animal Care and Use Committee of the
University of Alabama at Birmingham.
Primary telencephalic cell cultures
E14.5 telencephalic cells were dissociated as previously
described [39] and plated in a chemically defined serum-free
medium containing insulin, transferrin, selenium, progesterone,
putrescine, glucose and glutamine [39] followed by incubation at
37uC in humidified 5% CO2/95% air atmosphere for 48 h prior
to treatment. Cells were plated at 30,000 cells/well in 48 well
plates coated with poly-L-lysine and laminin. Cultured cells were
treated with tunicamycin or cytosine arabinoside (AraC) (Sigma
St. Louis, MO, USA) for 24h to measure cell viability and caspase-
activation.
Cells
SH-SY5Y cells were obtained from ATCC (CRL-2266) and
cultured in Minimum Essential Medium Eagle (Cellgro, Herndon,
VA, USA) and F12-K (ATCC, Manassas, VA, USA) medium
supplemented with 0.5% sodium pyruvate (Cellgro), 0.5% non-
essential amino acids (Cellgro), 1% penicillin/streptomycin
(Sigma), and 10% fetal bovine serum (FBS; HyClone, Logan,
UT, USA). Cells were plated at a density of 30,000 cells per well in
48 well plates and grown for 24 h prior to treatment. Cells were
treated with tunicamycin (1mM for 0–24h) or AraC (50mM for 24h)
for all experiments.
Cell Viability and Caspase Assays
Cell viability in SH-SY5Y cells and primary telencephalic
neurons was assessed by the Calcein AM assay. Briefly, cells were
washed in Locke’s buffer (154 mM NaCl, 5.6 mM KCl, 3.6 mM
NaHCO3, 2.3 mM CaCl2, 1.2 mM MgCl2, 5.6 mM glucose,
5 mM HEPES, pH 7.4). 5 mM Calcein AM (Molecular Probes,
Eugene, OR) was diluted in this buffer and added to cells; they
were then incubated at 37uC for 30 minutes. Calcein AM
conversion was measured using a fluorescence plate reader
(excitation 488 nM, emission 530 nM). To assess caspase activity
in vitro, we utilized the DEVD-AMC labeled caspase substrate
cleavage assay. Following treatment, cells were lysed in 100ml
buffer A (10 mM HEPES, pH 7.4, 42 mM KCl, 5 mM MgCl2,
1 mM DTT, 0.5% CHAPS, 10% sucrose, 1 mM PMSF, and
1mg/ml leupeptin) followed by 150 ml of buffer B (25 mM HEPES,
pH 7.4, 1 mM EDTA, 0.1% CHAPS, 10% sucrose, and 3 mM
DTT) containing 10 mM DEVD-AMC (Biomol, Plymouth Meet-
ing, PA) and incubated at 37uC for 30 minutes. Production of the
fluorescent AMC caspase-3 product was measured with a
fluorescence plate reader (excitation 360 nM, emission 460 nM).
Both assays were expressed in comparison to untreated controls.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde for 20 minutes at 4uC
followed by phosphate-buffered saline (PBS) wash and stored at
4uC. Cells were permeabilized with PBS-blocking buffer (PBS with
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for 30 minutes at room temperature (RT). The primary antibody
against cleaved caspase-3 (# 9661, Cell Signaling Technologies,
Danvers, MA) was incubated overnight at 4uC in PBS blocking
buffer without Triton. Plates were washed with PBS and a
horseradish peroxidase-conjugated horse anti-rabbit SuperPicture
(Zymed Laboratories Inc., South San Francisco, CA) secondary
antibody was applied for 1 hour at RT. Plates were washed with
PBS and immunoreactivity was detected using Tyramide Signal
Amplification (TSA) system (Perkin-Elmer Life Science Products,
Boston, MA). Following PBS washes the cells were counterstained
with bisbenzimide (2 mg/ml; Hoechst 33258; Sigma) and exam-
Figure 1. Tunicamycin produces a concentration- and time-dependent decrease in cell viability in SH-SY5Y cells concomitant with
caspase-3 activation. (A) Treatment of SH-SY5Y cells with tunicamycin (0.1–5mM) for 24 h caused a progressive decrease in cell viability as
measured by Calcein AM cleavage assay. (B) Treatment with tunicamycin (1mM) for 6–48 h caused a time-dependent decrease in cell viability and an
increase in caspase-3 like enzymatic activity (C), as measured by the DEVD-AMC cleavage assay. (D) Treatment with tunicamycin (1mM) for 24h also
produced an increase in cleaved caspase-3 immunoreactivity. (E) Treatment with tunicamycin (1mM) also produced an increase in levels of cleaved
caspase-3 as measured by immunoblotting. (F) Tunicamycin (1mM) treatment of SH-SY5Y cells upregulated markers of the UPR: BiP, phospho eIF2a
and CHOP on immunoblotting. Data points represent mean 6 SEM, with n=6.*p,0.05 by one-way ANOVA with Bonferroni post hoc test versus UT
controls.
doi:10.1371/journal.pone.0039586.g001
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cence. Images were captured using AxiovisionH software.
RNA extraction and Real Time PCR analysis
Cells were treated with tunicamycin at various time points or
with AraC and total RNA was extracted using the RNeasy Plus
minikit (Qiagen; Maryland, USA) according to the manufacturer’s
instructions. Real-time RT-PCR to measure Puma mRNA was
performed using TaqMan One-Step RT-PCR master mix
reagents (catalog no. 4309169; Applied Biosystems) and a Taqman
Gene Expression Assay (assay ID: Hs00248075_m1) using the
manufacturer’s handbook as a reference. Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH; assay ID: Hs99999905_m1)
was studied in parallel as an internal control. TaqMan RT-PCR
reactions were performed in 25-ml final volumes containing 5 ml
(10x dilution of stock) of RNA sample, AmpErase UNG (2x,
12.5 ml), MultiScribe reverse transcriptase and RNase inhibitor
(40x, 0.625 ml), primers and probe (20x, 1.25 ml), and RNase-free
water (5.625 ml). Quantitative real-time PCR was performed using
the ABI PRISM 7500 sequence detection system. Five 1-log serial
dilution reactions were conducted in duplicate. Data were
exported from ABI PRISM 7500 software into Microsoft Excel
and analyzed using the relative standard curve method. Cycle
threshold values for each serial dilution were plotted, and the
values were calculated from the y-intercept and slope of the
standard curve using the Excel Trendline option. These values
were then used to calculate the input amount of mRNA samples.
The input amount of target mRNA was normalized to GAPDH
mRNA as an endogenous control.
RNAi
Lentiviral shRNA (CHOP) constructs were purchased from
Open Biosystems (RHS4533-NM_004083). shRNAs were co-
transfected into 293FT cells together with packaging plasmids by
following the manufacturer’s protocol (Invitrogen ViraPower
TM
Lentiviral Expression Systems kit, Carlsbad, CA). The pLKO.1
lentivirus plasmid vector without a shRNA insert was used as a
negative control in experiments using the shRNA constructs.SH-
SY5Y cells were passaged and plated in a 6-well plate and allowed
to adhere for 24 h before infection. SH-SY5Y cells were
transduced (MOI=10) in the presence of polybrene overnight,
and the following day media were replaced by fresh media. After
24 h cells were selected by treating with media containing 1.5mg/
ml puromycin. Protein levels and experiments were assessed after
72 h.
Preparation of cell lysates
Preparation of whole cell lysates was performed as follows.
Briefly, cells were lysed by adding ice cold RIPA buffer (50 mM
Tris, pH 8.0, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1%
SDS, and 1.0% NP-40) supplemented with with 1% PMSF, 1%
protease inhibitor cocktail (Sigma) and 1% phosphatase inhibitor
cocktails (Sigma). Lysates were subject to constant agitation for
30 minutes at 4uC, sonicated and centrifuged at 12000g for
20 minutes to pellet out the cell debris. The supernatant was
transferred to a fresh tube, and the protein concentrations were
determined via Pierce BCA assay kit (Pierce). Nuclear–cytoplasmic
fractionation was performed using the NE-PER Nuclear and
Cytoplasmic Extraction Reagents kit (Thermo Fisher Scientific)
according to the manufacturer’s protocol and the protein
concentrations were determined via Pierce BCA assay kit (Pierce).
SDS-PAGE and Western blotting
Equal amounts of whole cell lysates (35 mg), and nuclear or
cytoplasmic fractions (20mg) were resolved by SDS-PAGE and
transferred to PVDF membranes. Blots were blocked for 1 h at
room temperature, 5% milk in wash buffer (200 mm Tris base,
1.37 M NaCl, 1% Tween 20, pH 7.6) followed by overnight
incubation with primary antibodies. Blots were probed for either
p53 (2524, Cell Signaling), phosho-p53 (9284, Cell Signaling), Akt
(9272, Cell Signaling), phospho-Akt (9271, Cell Signaling), Bip
(3177, Cell Signaling), CHOP (2895, Cell Signaling), eIF2a (2103,
Cell Signaling), phospho-eIF2a ( 3398, Cell Signaling), Akt (9272,
Cell Signaling), phospho- Akt (9271, Cell Signaling), phospho-
FoxO3a (2599, Cell Signaling) and cleaved caspase-3 (9661, Cell
Signaling), Puma (sc-19187, Santa Cruz), Bim ( B7929, Sigma) and
FoxO3a( 07-702, Millipore) with GAPDH (2118, Cell Signaling)
or HDAC (H-51, Santacruz Biotechnology) serving as a loading
Figure 2. ER stress in neuronal cells induces the expression of pro-apoptotic proteins PUMA and BIM. (A) Tunicamycin (1mM) induces a
time-dependent increase in PUMA and BIM protein levels. Though AraC caused an increase in PUMA and phospho p53 protein levels, tunicamycin-
induced increase in PUMA protein levels was not associated with an increase in phospho p53 levels. (B) Tunicamycin treatment also caused a robust
increase in Puma mRNA levels as measured by quantitative PCR. Data points represent mean 6 SEM, with n=3.*p,0.01 by one-way ANOVA/
Bonferroni post hoc test versus UT controls.
doi:10.1371/journal.pone.0039586.g002
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PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e39586Figure 3. Loss of Puma but not p53, protects against tunicamycin-induced cell death and caspase-3 activation. (A) PUMA-deficient
telencephalic neurons exhibited significantly less death after exposure to tunicamycin in comparison to wild-type telencephalic neurons from litter
mate controls. Similarly, PUMA-deficient telencephalic neurons were protected against AraC-induced cell death (B) PUMA-deficient telencephalic
neurons exhibited a significant attenuation in caspase-3 activation after exposure to tunicamycin or AraC in comparison to wild-type neurons. (C)
p53-deficient telencephalic neurons did not exhibit significant protection against tunicamycin-induced cell death although they were protected from
BH3-Only Molecules and CHOP Mediated Apoptosis
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with 16 Tris-buffered saline containing 0.1% Tween 20, then
incubated with appropriate secondary antibodies, for 1 h at room
temperature and washed. Signal was detected using ECL (Pierce)
chemiluminescence.
Co-Immunoprecipitation
Co-immunoprecipitation experiments were performed using the
Pierce Co-Immunoprecipitation Kit (26149, Pierce; Rockford, IL)
as per the manufacturer’s instructions. Briefly, 200mg of protein
lysates were pre-cleared using a control agarose resin to minimize
non specific binding. These lysates were then applied to columns
containing 1mg immobilized antibodies (FoxO3a or CHOP)
covalently linked to an amine-active resin and incubated overnight
at 4uC. Equal volumes of the lysates were also applied to columns
containing control resin and processed the same as the antibody
coupling resin for negative controls. The co-immunoprecipitate
was then eluted and analyzed by SDS-PAGE along with the input
controls.
Statistics
For experiments involving quantification, mean and SEM were
determined from at least 3 independent experiments with an ‘‘n’’
of one representing one gene disrupted mouse accompanied by
one wild-type litter mate control or separate experiments from
different SH-SY5Y passages. Effects of genotype for each age were
analyzed for significance using one-way or two-way ANOVA,
followed by Bonferroni test for all pair-wise comparisons. In all
cases, a p value of less than or equal to 0.05 was considered
significant.
Results
Tunicamycin induces apoptosis and an increase in
markers of ER stress in SH-SY5Y cells
Microscopic examination of SH-SY5Y cells treated with
tunicamycin (a protein N-glycosylation inhibitor and well charac-
terized ER stress inducing agent) [40], revealed cell shrinkage and
gradual cell detachment from culture dishes (data not shown).
Tunicamycin induced a concentration-(Fig. 1a) and time-depen-
dent (Fig. 1b) decrease in cell viability in SH-SY5Y cells as
measured by the Calcein-AM conversion assay. The decrease in
cell viability with tunicamycin treatment was accompanied by a
concomitant increase in caspase-3 like enzymatic activity as
measured by the DEVD-AMC cleavage assay (Fig. 1c) There was
also an increase in cleaved caspase-3 immunoreactivity (Fig. 1d.)
and an increase in cleaved caspase-3 protein levels by western blot
analysis (Fig. 1e). The induction of ER stress in SH-SH5Y cells
after treatment with tunicamycin was indicated by a robust
increase in the levels of BIP/GRP78 (Fig. 1f). We also observed an
increase in phosphorylated eIF2a levels suggesting that the
upstream arms of the UPR were being reliably activated (Fig. 1f).
In addition to an increase in the markers of the UPR, we observed
a time-dependent increase in the levels of CHOP, suggesting that
ER stress-dependent apoptotic pathways were being engaged in
response to prolonged tunicamycin exposure (Fig. 1f). To test the
stimulus-specific effects of tunicamycin on neuronal cells, we
compared it with AraC, a known genotoxic agent that causes cell
death through a p53- and PUMA-dependent mechanism [41]. In
contrast to tunicamycin treated cells, treatment of SH-SY5Y cells
with AraC did not cause an increase in markers of the UPR or an
increase in levels of CHOP (Fig. 1f).
ER stress causes an induction of BH3-only proteins PUMA
and BIM
Puma and Bim are two potent BH3-only genes whose expression
is known to be robustly increased in response to ER stress [13,14].
Consistent with previous reports, we detected an increase in
PUMA and BIM protein levels in response to tunicamycin
(Fig. 2a). Puma is a direct transcriptional target of the tumor
suppressor p53, which is activated by DNA damage, oncogene-
induced stress and certain other cytotoxic stimuli [37,42]. Previous
studies have shown that ER stress-induced PUMA expression is
largely indepdendent of p53 [13]. We also noted a significant
increase in Puma mRNA levels in SH-SH5Y cells treated with
tunicamycin (Fig. 2b) and consistent with previous reports, we did
not observe changes in the levels of phosphorylated or total p53 in
SH-SY5Y cells in response to tunicamycin in comparison to cells
treated with AraC (Fig. 2a).
PUMA deficiency significantly protects neurons against
ER stress induced-cell death and caspase activation
To assess the differential roles of PUMA, BIM and p53 in the
regulation of ER stress-induced neuronal cell death, we generated
primary telencephalic neuron cultures from Puma
2/2, Bim
2/2
and p53
2/2 E14.5 mice and treated them with tunicamycin or
AraC, and compared them to cultures prepared from wild-type
littermate controls. PUMA-deficient telencephalic neurons were
significantly protected from tunicamycin-induced cell death and
caspase-3 activation in comparison to wild-type cells (Fig. 3a and
3b). As we have previously reported, PUMA deficiency also
afforded significant protection against genotoxic stress-induced
apoptosis and caspase-3 activation (Fig. 3a and 3b). Though p53
deficiency attenuated AraC-induced apoptosis and caspase-3
AraC-induced cell death in comparison to wild-type telencephalic neurons. (D) p53-deficient telencephalic neurons exhibited a significant attenuation
in caspase-3 activation after exposure to AraC in comparison to wild-type litter control neurons but not after treatment with tunicamycin. (E) BIM-
deficient telencephalic neurons demonstrated no significant protection against tunicamycin-induced cell death in comparison to wild-type
littermates. The data represent mean 6 SEM, with n=5. *p,0.01 by two-way ANOVA/Bonferroni post hoc test compared to both the wild-type and
the knock-out treated group.
doi:10.1371/journal.pone.0039586.g003
Figure 4. ER stress causes a change in the AKT/FOXO3a axis.
Tunicamycin (1mM) induced a progressive dephosphorylation of AKT
(Ser 473) accompanied by a progressive dephosphorylation of FOXO3a
(Thr 32). In comparison to ER stress, genotoxic stress does not induce
changes in phospho AKT or phospho FOXO3a levels.
doi:10.1371/journal.pone.0039586.g004
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death or caspase-3 activation (Fig. 3c and 3d). Though we
observed a robust induction of BIM in SH-SY5Y cells in response
to tunicamycin, BIM-deficient telencephalic neurons were not
significantly protected against tunicamycin- or AraC-induced cell
death in comparison to wild-type littermate controls (Fig. 3e).
Figure 5. CHOP knockdown inhibits the induction of PUMA and BIM in neuronal cells in response to ER stress. (A) Knockdown of CHOP
in SH-SY5Y cells using shRNA ameliorated the induction of PUMA with tunicamycin in comparison to control cells. (B) Knockdown of CHOP also
attenuates the transcriptional induction of Puma mRNA in comparison to controls. (C) Knockdown of CHOP also causes a decrease in the activation of
BIM in comparison to control cells after treatment with tunicamycin. Data points represent mean 6 SEM, with n=3. *p,0.05 by 2-way ANOVA/
Bonferroni post hoc test vs. treated controls and **p,0.05 by 2-way ANOVA/Bonferroni post hoc test vs. treated CHOP knockdowns.
doi:10.1371/journal.pone.0039586.g005
Figure 6. CHOP knockdown prevents dephosphorylation of AKT and FOXO3a. (A) CHOP knockdown prevents dephosphorylation of AKT
(Ser 473) in comparison to control cells treated with tunicamycin. (B) CHOP knockdown prevents dephosphorylation of FOXO3a (Thr 32) in
comparison to control cells treated with tunicamycin.
doi:10.1371/journal.pone.0039586.g006
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To assess the potential role of the AKT-FOXO3a axis in
regulating both PUMA and BIM expression in response to ER
stress, we examined the levels of phosphorylated AKT (serine 473)
and its downstream target phosphorylated FOXO3a (threonine
32) in SH-SY5Y cells in response to tunicamycin. As reported
previously in neuronal cells [33], tunicamycin treatment caused a
time-dependent decrease in the levels of phosphorylated AKT and
a decrease in phosphorylated FOXO3a (Fig.4), suggesting an
activation of the AKT-FOXO3a axis in response to ER stress. In
contrast, treatment of cells with AraC did not induce dephos-
phorylation of AKT or FOXO3a, indicating that the activation of
this axis was specific to the induction of ER stress (Fig. 4).
Induction of Puma and Bim in response to ER stress is
CHOP-dependent
To assess the role of CHOP in inducing the BH3-only
molecules PUMA and BIM in response to ER stress, SH-SY5Y
cells transduced with pLKO.1 and CHOP shRNA were treated
with tunicamycin for 24h and compared to untreated controls.
CHOP knockdown resulted in a significant decrease in PUMA
protein (Fig. 5a) and Puma mRNA levels (Fig. 5b). As reported
previously, knockdown of CHOP expression led to a significant
attenuation in BIM protein levels in response to tunicamycin
treatment (Fig. 5c). These results suggest that CHOP directly
regulates the expression of pro-apoptotic proteins BIM and
PUMA in neuronal cells in response to ER stress.
Dephosphorylation of Akt and FOXO3a in response to ER
stress is CHOP-dependent
To determine whether ER stress inactivated AKT in a CHOP-
dependent manner, the expression of CHOP was selectively
inhibited by shRNA. Knockdown of CHOP prevented the
dephosphorylation of AKT (Ser473) induced by tunicamycin
(Fig. 6a). Knockdown of CHOP also prevented the dephosphor-
ylation of its downstream target FOXO3a (Thr32) (Fig. 6b). These
results suggest that CHOP may play a key role in regulating other
putative transcriptional regulators of BIM and PUMA expression
in neurons in response to ER stress.
CHOP interacts with FOXO3a in neuronal cells in
response to ER stress
ER stress causes an induction of the pro-apoptotic transcription
factor CHOP that then activates its various downstream targets.
Similarly, as previously reported [33] FOXO3a undergoes
dephosphorylation and nuclear translocation in neuronal cells in
response to ER stress in a PI3K-AKT dependent manner. To
assess the localization of CHOP and FOXO3a in response to ER
stress, we performed nuclear and cytosolic fractionation studies
and assessed the levels of CHOP and total FOXO3a in these
fractions. Consistent with previous reports, we found an increase
in CHOP protein levels in the nuclear fraction after treatment
with tunicamycin. Similarly, we observed an increase in the levels
of FOXO3a in the nuclear fraction after treatment with
tunicamycin, while the transcriptionally inactive, phosphorylated
FOXO3a remained in the cytosolic fraction (Fig. 7a). Thus our
results suggest alterations in the nuclear fractions of the key
transcription factors CHOP and FOXO3a in response to
tunicamycin treatment. To test for a functional interaction
Figure 7. CHOP directly interacts with FOXO3a in response to
ER stress. (A) Nuclear and cytoplasmic fractions from untreated SH-
SY5Y cells and those treated with tunicamycin (1mM) for 24h were
examined for levels of total and phosphorylated FOXO3a and CHOP.
GAPDH was used as a loading control for whole cell lysates or
cytoplasmic fractions, while HDAC was used as a loading control for
nuclear fractions (B) Cell lysates of SH-SY5Y cells treated with
tunicamycin or controls were subjected to immunoprecipitation using
FOXO3a polyclonal antibody or control IgG. CHOP protein was detected
from immunoprecipitates by western blotting in comparison to input
controls.
doi:10.1371/journal.pone.0039586.g007
Figure 8 Proposed model for direct and indirect activation of
PUMA and BIM by CHOP.
doi:10.1371/journal.pone.0039586.g008
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performed a co-immunoprecipitation experiment. Protein extracts
from untreated and tunicamycin treated cells were subjected to
Co-IP with an antibody against FOXO3a or control resin, and
subsequently analyzed through Western blotting with an anti-
CHOP polyclonal antibody. Representative results demonstrate
that CHOP was co-precipitated with the anti-FOXO3a antibody
but not with the control resin in comparison to the input controls
(Fig. 7b).
Discussion
Increasing evidence points to the role of ER stress in the
pathophysiology of various neurodegenerative diseases. Aberrant
aggregated proteins and elevation of markers of ER stress have
been observed in dying neurons in animal models of ischemia [43],
Parkinson disease [20], Huntington disease [44] and Alzheimer
disease [45]. It is thus essential to delineate the mechanisms by
which ER stress can induce apoptosis in neuronal cells. Our
current results support previous studies indicating that ER stress in
neuronal cells upregulates key pro-apoptotic molecules PUMA
and BIM, and that PUMA critically regulates ER stress-induced
neuronal apoptosis. Loss of CHOP expression attenuated PUMA
and BIM induction in response to ER stress in neuronal cells. Our
results also indicate that CHOP may potentially interact with
FOXO3a, a common upstream transcriptional regulator of Puma
and Bim expression in neuronal cells in response to ER stress
(Fig. 8), though further knockdown studies are needed in support
of our preliminary data and to determine the functional
significance of this interaction. These findings highlight the
complex roles of CHOP in mediating ER stress-induced apoptosis
by transcriptional mechanisms and also by mediating protein-
protein interactions.
The BH3-only proteins sense and relay stress signals, and are
activated in a cell-type- and stimulus-dependent manner [9]. The
BH3-only proteins activate BAX and BAK directly or indirectly,
by engaging and neutralizing their pro-survival relatives, which
otherwise constrain BAX and BAK from causing mitochondrial
outer membrane permeabilization [8]. PUMA and BIM have
been implicated in regulating apoptosis in response to ER stress
[14,16,46] and consistent with previous studies, we show that
PUMA and BIM are both induced in neuronal cells in response to
ER stress, though the transcriptional induction of PUMA alone is
critical for the apoptotic response. We and others have previously
demonstrated that the induction of PUMA in response to
genotoxic stress is mediated by p53 [41,47]. However, we did
not observe changes in upstream p53 signaling in response to ER
stress in neuronal cells, and p53-deficient telencephalic neurons
were not protected against tunicamycin-induced cell death or
caspase-3 activation suggesting that PUMA-dependent ER stress-
induced death occurs independent of p53 expression.
The most significant ER stress-induced apoptotic pathway is
mediated through CHOP. CHOP/GADD153 is a bZiP tran-
scription factor that is induced through the ATF6 and PERK
UPR pathways [22,48]. One of the more widely cited mechanisms
of CHOP-induced apoptosis is suppression of the pro-survival
protein BCL2 [49]. Other CHOP-induced molecules that have
been implicated in apoptosis include death receptor-5 (DR5;
TRAIL-R2) and Tribbles-related protein 3 (TRB3). A previous
study using multiple ER stressors demonstrated the importance of
BIM in ER-stress-induced apoptosis in some cell types but not
others. ER stress increased BIM levels through both decreased
proteasomal degradation and CHOP C/EBPa-mediated gene
induction [14]. Our results indicate that CHOP regulates
expression of both PUMA and BIM in neuronal cells in response
to ER stress, but that PUMA plays a more significant role than
BIM in mediating death. Although our study clearly demonstrates
the important involvement of CHOP signaling in ER-stress-
induced neuronal apoptosis, it is evident that inhibition of this
pathway does not completely abrogate the transcriptional induc-
tion of PUMA or cell death. This suggests that additional
transcriptional factors may contribute to PUMA activation during
ER-stress-induced apoptosis or PUMA may co-operate with other
BH3-only proteins such as BIM and BID to mediate the full
apoptotic response. One such key transcription factor that is
known to modulate neuronal expression of PUMA and BIM in
response to cytokine withdrawal is FOXO3a [34]. FOXO3a
undergoes dephosphorylation and nuclear translocation in re-
sponse to ER stress and this modification allows its transcriptional
activation [33], though its downstream targets in response to ER
stress are not well defined.
CHOP protein is composed of two known functional domains,
an N-terminal transcriptional activation domain and a C-terminal
basic-leucine zipper (bZIP) domain consisting of a basic amino-
acid-rich DNA-binding region followed by a leucine zipper
dimerization motif [22,50]. Deletion mutant analysis of CHOP
revealed that the bZIP domain is important for CHOP-induced
apoptosis [25]. The high conservation (.90%) in the bZIP
domain of the C/EBP members allows for formation of
homodimers and heterodimers of the members [22]. Furthermore,
CHOP can enhance the transcriptional activation of AP-1 by
tethering to the AP-1 complex without direct binding of DNA
[51]. A growing body of evidence also suggests that CHOP-
mediated apoptosis occurs through non-transcriptional mecha-
nisms such as protein–protein interactions [52,53]. Thus, the
regulation of CHOP-mediated apoptosis and its downstream
targets is complex. According to a recent report, CHOP co-
operates with AP-1 to mediate PUMA expression in a model of
hepatic lipoapoptosis [54]. TRB3 a recently characterized
downstream target of CHOP, was shown to directly interact with
AKT and suppress the phosphorylation of this kinase in liver [55].
Our results indicate that a knockdown of CHOP expression in
SH-SY5Y cells causes a decrease in PUMA protein and Puma
mRNA levels in response to ER stress, suggesting that CHOP is a
direct regulator of PUMA expression in response to ER stress.
However, CHOP knowkdown does not completely restore PUMA
expression to baseline levels suggesting that alternate transcription
factors may also play a role. Our results indicate that CHOP
knockdown inhibits the dephosphorylation of AKT and FOXO3a
in response to ER stress in neuronal cells, suggesting that CHOP
can feed into alternate signaling pathways such as the AKT/
FOXO3a axis that may play a role in regulating expression of
downstream pro-apoptotic genes Puma and Bim. The observed
interaction between CHOP and FOXO3a suggests that CHOP
regulation of downstream target genes such as Puma and Bim can
also occur through modulation of the AKT/FOXO3a axis.
In summary, our study extends and further integrates present
knowledge regarding the mechanisms linking ER stress, CHOP
and the induction of BH3-only molecules in ER stress-induced
apoptosis. Insights into the network regulating CHOP-mediated
apoptosis will potentially provide a basis for new CHOP-targeted
therapeutic approaches to ER stress-associated neurodegenerative
diseases.
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